BIOkey International (BKYI)
(Delayed Data from NSDQ)
$1.81 USD
-0.09 (-4.58%)
Updated Jun 7, 2024 03:46 PM ET
After-Market: $1.73 -0.08 (-4.61%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BKYI 1.81 -0.09(-4.58%)
Will BKYI be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for BKYI based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BKYI
Identity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ET
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
BIO-key International receives notice of non-compliance from Nasdaq
BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week
12 Information Technology Stocks Moving In Wednesday's After-Market Session